MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1176/appi.ps.202100617

Медицинская библиотека · Psychiatric services (Washington, D.C.) · 2022

Long-Term Benzodiazepine Use and Discontinuation Among Patients in the U.S. Veterans Health Administration.

Timko Christine, Hoggatt Katherine J, Esmaeili Aryan, Lewis Eleanor, Lor Mai Chee, Maust Donovan T, Nevedal Andrea L

СтатьяПоддержка правительства СШАПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Although long-term benzodiazepine use is not recommended, patients are often prescribed benzodiazepines for >30 days (long-term use). Data from the Veterans Health Administration (VHA) may inform efforts to discontinue such use. This study sought to describe benzodiazepine use and discontinuation among VHA patients and compared patients who continued and discontinued use.

METHODS

The study used nationwide electronic health record data for all VHA-enrolled patients (age ≥18) from fiscal year (FY) 2019 (N=6,032,613). The primary outcome, benzodiazepine discontinuation, was defined as no prescription refill for 120 days.

RESULTS

In FY2019, 3.5% of VHA enrollees were prescribed benzodiazepines for >30 days, which was 72.0% of those prescribed benzodiazepines. One-third of veterans prescribed long-term benzodiazepines discontinued use. Continuation was more likely among patients who were older, not Black, taking benzodiazepines longer, and taking higher doses. When demographic factors were controlled, patients who continued long-term use were more likely to have a diagnosis of anxiety, posttraumatic stress disorder (PTSD), bipolar disorder, or psychosis and less likely to have depression or an alcohol or drug use disorder. Continuation was associated with a lower likelihood of sleep and cardiopulmonary disorders and of dementia.

CONCLUSIONS

Higher discontinuation prevalence among patients with substance use disorders, dementia, or cardiopulmonary disorders is encouraging. However, the challenge remains of discontinuing long-term use among patients who are White, older, or diagnosed as having anxiety, PTSD, bipolar disorder, or psychosis. There is a need to identify provider, patient, and contextual factors driving long-term benzodiazepine use in these patient groups to effectively apply evidence-based discontinuation strategies.

Для цитирования: Timko Christine, Hoggatt Katherine J, Esmaeili Aryan, Lewis Eleanor, Lor Mai Chee, Maust Donovan T, Nevedal Andrea L. Long-Term Benzodiazepine Use and Discontinuation Among Patients in the U.S. Veterans Health Administration.. Psychiatric services (Washington, D.C.). 2022. DOI: 10.1176/appi.ps.202100617.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.